Acumen Pharmaceuticals, Inc. (ABOS) Earnings
|
Expand Research on ABOS
| Next EPS Date | 8/17/26 | EPS Growth Rate | +48.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -13.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q226 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 | Q126 | -$0.33 | -$0.37 | +$0.04 | N/A | N/A | N/A |  | | Details | |
| 3/26/26 |
Q425 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.68 | -$0.51 | -$0.17 | N/A | N/A | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.48 | -$0.51 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 3/31/25 |
Q424 | N/A | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/24 | Q324 | -$0.50 | -$0.36 | -$0.14 | N/A | N/A | N/A | | | Details |
